Understanding chronic symptoms after minimally invasive lung surgery for early-stage lung cancer
Prospective Observational Study of Postoperative Chronic Operation-related Symptoms and Long-term Survival Quality After Minimally Invasive Lung Surgery
This study looks at how patients feel after having a special lung surgery for early-stage lung cancer, focusing on long-lasting pain and cough to see how it affects their quality of life.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 500 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Fujian Medical University Union Hospital Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Fuzhou, Fujian) |
| Trial ID | NCT06016881 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on patients who have undergone single-port thoracoscopic surgery for stage I lung cancer or benign lesions. It aims to assess the long-term postoperative quality of life, particularly looking at chronic pain and cough that may arise after surgery. By emphasizing the psychological state and overall well-being of patients, the study seeks to identify factors that contribute to postoperative chronic symptoms and their impact on quality of life. The findings could help improve recovery management strategies for patients undergoing minimally invasive lung surgery.
Who should consider this trial
Good fit: Ideal candidates include adults aged 18 and older who have undergone single-port thoracoscopic surgery for stage I lung cancer or benign lesions.
Not a fit: Patients with a history of chronic pain or cough requiring daily medication, or those with previous thoracic surgery, may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to enhanced postoperative care and improved quality of life for patients recovering from lung surgery.
How similar studies have performed: While there is limited research specifically addressing chronic symptoms post-lung surgery, studies on quality of life in cancer patients have shown promising results in improving patient outcomes.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Aged 18 years or above; 2. Received single-port thoracoscopic surgery; 3. Diagnosed with stage I lung cancer or benign lesions by histologic examination; 4. Volunteered to participate in the study and signed an informed consent form. Exclusion Criteria: 1. Previous thoracic surgery 2. Any type of chronic pain, requiring daily use of analgetics 3. Any type of chronic cough that requires daily medication 4. pregnant 5. Breast feeding 6. contraindications to NSAID 7. Combination of other tumors requiring chemotherapy or radiotherapy
Where this trial is running
Fuzhou, Fujian
- Maohui Chen — Fuzhou, Fujian, China (Recruiting)
Study contacts
- Study coordinator: Maohui Chen
- Email: 757860733@qq.com
- Phone: +8618659181171
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.